Discover
KAPA
Kairos Pharma, Ltd.
1.73
200 x 1.76
400 x 2.01
bid
ask
-
0.08
4.42%
300 @ 07:50 PM
1.76 +0.03 (1.73%)
| Ytd | -65.19% | |
| 1y | -81.56% |
1.72
day range
1.81
1.58
52 week range
9.38
| Open | 1.81 | Prev Close | 1.81 | Low | 1.72 | High | 1.81 | Mkt Cap | 5.86M |
| Vol | 168.74K | Avg Vol | 334.26K | EPS | -1.96 | P/E | N/A | Forward P/E | -7.46 |
| Beta | 1.48 | Short Ratio | 0.13 | Inst. Own | 0.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.09 | 200-d Avg | 3.75 | 1yr Est | 9.00 |
| Income Statement | |||
| Operating Expenses | 1.42M | ||
| Research and Development Expense | 619.00K | ||
| Selling, General and Administrative Expense | 798.00K | ||
| Operating Income | -1.42M | ||
| Net Income | -1.39M | ||
| Net Income Common Stock | -1.39M | ||
| Net Income Common Stock (USD) | -1.39M | ||
| Consolidated Income | -1.39M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -1.39M | ||
| Earning Before Interest & Taxes (USD) | -1.39M | ||
| Weighted Average Shares | 21.42M | ||
| Weighted Average Shares Diluted | 21.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.63M | ||
| Cash and Equivalents (USD) | 2.63M | ||
| Current Assets | 3.17M | ||
| Total Assets | 4.46M | ||
| Current Liabilities | 265.00K | ||
| Total Liabilities | 265.00K | ||
| Accumulated Retained Earnings (Deficit) | -17.30M | ||
| Shareholders Equity | 4.19M | ||
| Shareholders Equity (USD) | 4.19M | ||
| Assets Non-Current | 1.28M | ||
| Trade and Non-Trade Payables | 265.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.00K | ||
| Net Cash Flow from Financing | -37.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.05M | ||
| Issuance (Purchase) of Equity Shares | 7.00K | ||
| Net Cash Flow from Operations | -1.01M | ||
| Share Based Compensation | 259.00K | ||